960
Participants
Start Date
December 31, 2005
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2007
Central Venous Catheter
7-French x 20-cm, triple lumen, short-term CVC vs. 7-French x 20-cm, triple lumen, short-term CVC with an anti-infective polymer coating, applied to the outer surface that contains the active pharmaceutical ingredient 5-fluorouracil (5-FU). The Angiotech CVC uses a 50µg/linear cm dose of 5-FU
Drexel University College of Medicine, Philadelphia
Christiana Care Research Institute, Newark
Winchester Medical Center, Winchester
University of Virginia, Department of Anesthesiology, Charlottesville
Atlanta Institute for Medical Research Inc, Decatur
Florida Research Network, LLC, Gainesville
Cardio-Thoracic Surgeons, P.C., Birmingham
St Vincent Mercy Medical Center, Bldg 1, Toledo
Medical University of Ohio, Toledo
Pulmonary and Critical Care Medicine, Cincinnati
Rapid City Regional Hospital, Rapid City
Kerry Thibodeaux, M.D., Opelousas
Universty of Oklahoma HSC, Oklahoma City
Denver Health Medical Center, Denver
Pulmonary Center Sharp Memorial Hospital, San Diego
Pulmonary Consultant Group, Orange
Kaiser Permanente Santa Teresa, San Jose
Franciscan Health System Research Center, Tacoma
UMASS Medical School, Dept of Anesthesiology, Worcester
Newark Beth Israel Hospital, Newark
Rhode Island Hospital, Providence
Lead Sponsor
Angiotech Pharmaceuticals
INDUSTRY